Genetic Study for Patients with Alport Syndrome
Genotype-Phenotype Correlations in Patients With Alport Syndrome
- Sex
- Any
- Study type
- Observational
- Participants needed
- 8,165 (estimated)
- Sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Other
This trial is looking for families and patients with a history of kidney bleeding. If you join, you will undergo genetic testing related to Alport syndrome.
You may be able to join if
- I am up to 99 years old.
- I am any sex.
- I have a family history of kidney bleeding.
- I have signed the informed consent.
You may not be able to join if
- I have polycystic kidney disease.
- I have hypertensive nephropathy.
- I have been diagnosed with other kidney diseases.
- I have an incomplete medical history or clinical data.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityAlport syndrome (AS) is caused by pathogenic variants in the type IV collagen genes COL4A3, COL4A4, and COL4A5. This study aims to enroll families and patients with a history of renal hematuria in 27 hospitals and detect these three genes for AS screening. This study also aims to analysis the effect of COL4A3/COL4A4/COL4A5 genotype on the development of kidney disease.
Loading trial locations…
No contact information available.